The idea that gut health affects organs seemingly unrelated to digestion isn't new. The "gut-brain axis" has two decades of published research behind it. A "gut-eye axis" is a newer but genuinely active extension of that same research direction — and it's the core positioning behind VisiFlora's gut-support ingredients (see our full ingredients page).
A 2023 systematic review searched PubMed for clinical studies examining gut microbiota and ocular pathology. Out of 828 candidate publications, 25 met inclusion criteria — and of those, only four were interventional studies (testing probiotics or fecal microbiota transplant), mostly for conditions like chalazion or uveitis [1]. The review's conclusion was measured: "the gut-eye axis appears to hold clinical relevance, but current data is limited in sample size and design."
A separate 2024 review describes the plausible mechanisms: gut microbiota may influence ocular health through immune modulation, maintenance of the blood-retinal barrier, and production of metabolites — with dysbiosis potentially contributing to inflammation in conditions including dry eye, uveitis, diabetic retinopathy, and age-related macular degeneration [2]. A broader narrative review synthesizing over 100 sources reached a similar conclusion: growing evidence supports the gut-eye axis concept, but it remains an area of active investigation rather than settled clinical fact [3].
Ingredients like grape seed extract, quercetin, rutin, and taurine are included in VisiFlora because of their individually studied roles in gut-barrier integrity and inflammation — not because the specific formula has been shown to improve eyesight through the gut. That's a meaningfully different, more honest claim, and it's the standard we hold every page on this site to. See our VisiFlora ingredients page for how this plays out in the full formula.